Search

Your search keyword '"Izquierdo, Luis"' showing total 1,631 results

Search Constraints

Start Over You searched for: Author "Izquierdo, Luis" Remove constraint Author: "Izquierdo, Luis"
1,631 results on '"Izquierdo, Luis"'

Search Results

1. Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination

3. Interface Fluid Syndrome After Descemet Membrane Endothelial Keratoplasty in Patients With History of Postlaser In Situ Keratomileusis.

12. Dual Vocational Education and Training and Policy Transfer in the European Union Policy: The Case of Work-Based Learning and Apprenticeships

16. Eye Rubbing and Keratoconus

21. Sustained seropositivity up to 20.5 months after COVID-19

22. SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia

24. Inter-individual and inter-regional variability of breast milk antibody reactivity to bacterial lipopolysaccharides.

25. Testing the tourism led growth hypothesis: A nonsensical exercise?

26. Is the tourism-led growth hypothesis valid after the COVID-19 pandemic? The case of Spain.

29. Long-Term Exposure to Air Pollution and COVID-19 Vaccine Antibody Response in a General Population Cohort (COVICAT Study, Catalonia)

30. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies

33. RTS,S/AS02A Malaria Vaccine-Induced IgG Responses Equally Recognize Native-Like Fucosylated and Nonfucosylated Plasmodium falciparum Circumsporozoite Proteins

35. EMPOWERING ENERGY COMMUNITIES: THREE METHODS TO DISTRIBUTE SAVINGS IN LOCAL ENERGY MARKETS.

36. N-acetylglucosamine supplementation fails to bypass the critical acetylation of glucosamine-6-phosphate required for Toxoplasma gondii replication and invasion.

37. Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings.

39. Beyond the MEP Pathway: A novel kinase required for prenol utilization by malaria parasites

42. High-resolution kinetics and cellular determinants of antibody response to SARS-CoV-2 over two years after COVID-19 vaccination

49. Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses

50. Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain

Catalog

Books, media, physical & digital resources